Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Each production batch undergoes extensive testing to verify: Compound identity confirmation Assay content verification Purity assessment Molecular ion mass verification Retention time confirmation FTIR spectrum identification Endotoxin analysis Microbial contamination screening Heavy metal screening Complete batch traceability Independent laboratory testing helps ensure every batch provides reliable, reproducible research material suitable for advanced scientific investigation
Comparative Performance Across Research Contexts Key Takeaways Cerebrolysin delivers a mixture of neurotrophic peptides mimicking BDNF, NGF, CNTF, and GDNF, requiring IV administration and daily dosing to maintain CNS levels due to short plasma half-life under 30 minutes
, ,
Within research environments, GHK-Cu is widely studied in relation to: Skin structure and skin quality Cell renewal and tissue processes Support of connective tissue and matrix structures Biological processes associated with aging Packaging & storage Contents: 1 vial of GHK-Cu 50 mg Storage: Store cool and dry (2-8 C), protected from light Why choose GHK-Cu 50 mg
After 46 weeks of treatment: 0.6 mg dose: 6.2% mean body weight reduction 2.4 mg dose: 12.5% mean body weight reduction 3.6 mg dose: 13.2% mean body weight reduction 4.8 mg dose: 14.9% mean body weight reduction (all randomized) 4.8 mg dose: 18.7% mean body weight reduction (completers only) Placebo: 2.8% mean body weight reduction Among completers at the 4.8 mg dose, 68.8% achieved at least 10% weight loss, 67% achieved at least 15%, and 40% achieved at least 20% weight loss
